Skip to main content
Log in

Which strategy holds most promise for women with HNPCC?

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Kwon JS, Sun CC, Peterson SK, White KG, Daniels MS, Boyd-Rogers SG, Lu KH.Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome. Cancer 113: 326-335, No. 2, 15 Jul 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Which strategy holds most promise for women with HNPCC?. Pharmacoecon. Outcomes News 559, 13 (2008). https://doi.org/10.2165/00151234-200805590-00039

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805590-00039

Keywords

Navigation